Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-65,456
Closed -$783K 2410
2024
Q2
$783K Buy
65,456
+52,291
+397% +$668K ﹤0.01% 1117
2024
Q1
$183K Buy
+13,165
New +$153K ﹤0.01% 1790
2023
Q3
Sell
-30,152
Closed -$469K 2398
2023
Q2
$469K Buy
+30,152
New +$486K ﹤0.01% 1391
2022
Q4
Sell
-83,215
Closed -$1.64M 2461
2022
Q3
$1.64M Buy
83,215
+55,667
+202% +$1.27M 0.02% 675
2022
Q2
$544K Buy
+27,548
New +$713K 0.01% 1418
2021
Q4
Sell
-90,826
Closed -$4.55M 3179
2021
Q3
$4.55M Buy
+90,826
New +$4.43M 0.03% 343
2020
Q4
Sell
-18,464
Closed -$485K 1850
2020
Q3
$485K Buy
+18,464
New +$429K 0.01% 888
2020
Q1
Sell
-17,322
Closed -$444K 781
2019
Q4
$444K Buy
+17,322
New +$417K 0.02% 571

Other funds holding BALY

HRT Financial's BALY Position: Q3 2024 in Review

HRT Financial sold out of Bally's (BALY) in Q3 2024, closing a stake of 65,456 shares — an estimated $783K sold.

HRT Financial first reported a position in BALY in Q4 2019 and held it in 8 quarters. The position peaked at $4.55M in Q3 2021. 130 funds tracked by Wall St. Rank hold BALY as of Q3 2024.

  • HRT Financial reported no remaining Bally's position as of Q3 2024 after selling out during the quarter.
  • HRT Financial sold 65,456 Bally's shares in Q3 2024, an estimated $783K.
  • HRT Financial first reported a position in Bally's in Q4 2019 and held it in 8 quarters.
  • HRT Financial's Bally's position peaked at $4.55M in Q3 2021.
  • 130 funds tracked by Wall St. Rank held Bally's as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.